Read + Share
Saw SPL, Low YF, Lai GGY, Chan LL, et al. Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after
progression on first-line osimertinib in advanced EGFR-mutated NSCLC. Lung Cancer 2024;193:107856.
PMID: 38889498
|
 |
|
Saw SPL, Low YF, Lai GGY, Chan LL, et al. Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after
progression on first-line osimertinib in advanced EGFR-mutated NSCLC. Lung Cancer 2024;193:107856.
PMID: 38889498
|
|
|
|